Research evidence suggests a dose–response relationship for the association between
cannabis use and risk of psychosis. Such relationship seems to reflect an increased risk of …

The following chapter offers an overview of results of experimental studies conducted
among healthy individuals examining the effects of acute administration of Δ9-THC and …

Community-based studies suggest that cannabis products that are high in Δ9-
tetrahydrocannabinol (THC) but low in cannabidiol (CBD) are particularly hazardous for …

OBJECTIVE: Cannabis is associated with psychotic outcomes in numerous studies, an effect
that is commonly attributed to Δ 9-tetrahydrocannabinol (Δ 9-THC). An increasing number of …

Cannabis use has been associated with psychosis and cognitive dysfunction. Some
evidence suggests that the acute behavioral and neurocognitive effects of the main active …

Abstract Purpose of Review The lack of clarity about the effect of cannabis use on cognition
may be attributable to the considerable heterogeneity among studies in terms of cannabis …

Background Approximately 188 million people use cannabis yearly worldwide, and it has
recently been legalised in 11 US states, Canada, and Uruguay for recreational use. The …

Abstract Cannabidiol (CBD) and Δ 9-tetrahydrocannabinol (THC) have been the most
investigated cannabinoids at the human and preclinical levels, although the neurobiological …

BackgroundRecent work suggests that heavy use of cannabis is associated with an
increased risk of schizophrenia-like psychosis. However, there is a dearth of experimental …

Background Although δ-9-tetrahydrocannabinol (THC), the main cannabinoid from the
cannabis plant, is responsible for the psychotomimetic effects of cannabis, cannabidiol …